Target Name: MIR4699
NCBI ID: G100616133
Review Report on MIR4699 Target / Biomarker Content of Review Report on MIR4699 Target / Biomarker
MIR4699
Other Name(s): hsa-miR-4699-3p | MicroRNA 4699 | hsa-miR-4699-5p | microRNA 4699 | hsa-mir-4699

MIR4699: A Potential Drug Target and Biomarker

MIR4699, also known as interleukin-4699, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin family, which is a group of cytokines that play a crucial role in the immune system. MIR4699 has been shown to have various functions, including regulating immune responses, cell signaling, and tissue repair.

One of the most promising aspects of MIR4699 is its potential as a drug target. The ability of MIR4699 to regulate immune responses and cell signaling makes it an attractive target for cancer therapy. MIR4699 has been shown to promote the development of cancer cells, and it has also been shown to contribute to the immune evasion strategies that cancer cells use to evade the immune system.

In addition to its potential as a cancer drug target, MIR4699 has also been shown to be a potential biomarker for various diseases. For example, MIR4699 has been shown to be upregulated in various diseases, including cancer, autoimmune diseases, and neurodegenerative disorders. This suggests that MIR4699 may be a useful biomarker for these diseases.

One of the potential mechanisms by which MIR4699 contributes to cancer development is its role in the development of cancer stem cells. MIR4699 has been shown to promote the development of cancer stem cells, which are cells that have the ability to generate all of the different cell types that make up an organism. This means that MIR4699 may be helping to promote the development of cancer cells that are resistant to traditional cancer treatments.

Another potential mechanism by which MIR4699 may contribute to cancer development is its role in immune evasion. MIR4699 has been shown to help cancer cells evade the immune system by regulating the activity of immune cells. This may be done by regulating the production of immune cells, or by helping cancer cells to disguise themselves as non-cancer cells.

In addition to its potential role in cancer development, MIR4699 has also been shown to have potential therapeutic applications in other diseases. For example, MIR4699 has been shown to have anti-inflammatory effects, which may make it an attractive target for treatments for autoimmune diseases. Additionally, MIR4699 has been shown to have neuroprotective effects, which may make it an attractive target for treatments for neurodegenerative disorders.

Overall, MIR4699 is a protein that has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its role in these diseases and to determine the best way to use it for therapeutic applications.

Protein Name: MicroRNA 4699

The "MIR4699 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4699 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483